1997
DOI: 10.1073/pnas.94.7.3229
|View full text |Cite
|
Sign up to set email alerts
|

AIM1 , a novel non-lens member of the βγ-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma

Abstract: AIM1 is a novel gene whose expression is associated with the experimental reversal of tumorigenicity of human malignant melanoma. The predicted protein product of the major 4.1-kb transcript shows striking similarity to the ␤␥-crystallin superfamily. All known members of this superfamily contain two or four characteristic motifs arranged as one or two symmetrical domains. AIM1, in contrast, contains 12 ␤␥ motifs, suggesting a 6-domain structure resembling a trimer of ␤-or ␥-crystallin subunits. The structure o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
119
1
3

Year Published

1998
1998
2009
2009

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 140 publications
(128 citation statements)
references
References 31 publications
5
119
1
3
Order By: Relevance
“…Although germline p16 INK4 (and p19 ARF ) mutations are present in some families with hereditary melanoma, p16 INK4 mutations are uncommon in sporadic melanoma, and while this gene may be inactivated via another mechanism (such as methylation or homozygous deletion) there is still some debate as to whether this is the sole target of 9p loss or whether there are additional relevant tumour suppressor genes on 9p (Fountain et al, 1992;Holland et al, 1994;Hussussian et al, 1994;Kamb et al, 1994;Ohta et al, 1994;Gruis et al, 1995a,b;Merlo et al, 1995;Puig et al, 1995;Quelle et al, 1995;Flores et al, 1996;Healy et al, 1996b;Kim et al, 1997;Wiest et al, 1997). Candidate tumour suppressor genes on 6q and 10q include AIM1 and PTEN/MMAC1 respectively, however, whether these genes are inactivated during primary cutaneous melanoma development and progression is unclear at present (Ray et al, 1997;Li et al, 1997;Steck et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Although germline p16 INK4 (and p19 ARF ) mutations are present in some families with hereditary melanoma, p16 INK4 mutations are uncommon in sporadic melanoma, and while this gene may be inactivated via another mechanism (such as methylation or homozygous deletion) there is still some debate as to whether this is the sole target of 9p loss or whether there are additional relevant tumour suppressor genes on 9p (Fountain et al, 1992;Holland et al, 1994;Hussussian et al, 1994;Kamb et al, 1994;Ohta et al, 1994;Gruis et al, 1995a,b;Merlo et al, 1995;Puig et al, 1995;Quelle et al, 1995;Flores et al, 1996;Healy et al, 1996b;Kim et al, 1997;Wiest et al, 1997). Candidate tumour suppressor genes on 6q and 10q include AIM1 and PTEN/MMAC1 respectively, however, whether these genes are inactivated during primary cutaneous melanoma development and progression is unclear at present (Ray et al, 1997;Li et al, 1997;Steck et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…Three other genes at this locus, C6orf203, PREP and AIM1, were marginally downregulated (between 2 and 1.5 fold), but only AIM1 has been implicated in tumor suppression in melanoma. 40 We, therefore, focused our attention on ATG5, PRDM1 and AIM1.…”
Section: Genomic Studies On Natural Killer-cell Malignancies J Iqbal mentioning
confidence: 99%
“…Some members of this superfamily are Protein S (2), Spherulin 3a (3,4), Streptomyces killer toxin-like protein (SKLP) (5), cargo proteins from Tetrahymena thermophila (6), AIM1 (absent in melanoma) (7), epidermis differentiation-specific proteins (8,9), yeast killer toxin WmKT (10), and Streptomyces metalloproteinase inhibitor (SMPI) (11). These members show structural similarity despite relatively low sequence identity, which reflects the functional diversity found among these proteins.…”
mentioning
confidence: 99%